CAR T cell therapy makes strides in tackling Hodgkin lymphoma
CAR-T cell therapy has been used to treat Hodgkin lymphoma with remarkable success for the first time in an early phase clinical trial.
Read MoreCAR-T cell therapy has been used to treat Hodgkin lymphoma with remarkable success for the first time in an early phase clinical trial.
Read MoreA novel strategy can potentially address a major challenge to the current treatment for CNV, the leading cause of irreversible blindness in the elderly.
Read MoreCancer cell clusters are more effective than single cells at spreading cancer in the body, and researchers at Baylor College of Medicine found out why.
Read MoreDetailed 3-D studies reveal how the androgen receptor is put together as a functional complex that drives prostate cancer.
Read MoreNano-radiomics analysis of imaging data assesses changes in the tumor microenvironment that cannot be detected with conventional imaging methods.
Read MorePolyA-miner enables scientists to evaluate the contribution of alternative polyadenylation to gene regulation in health and disease.
Read MoreClinical trial of novel personalized CAR T cell immunotherapy provides clues into what mediated exceptional patient recovery.
Read MoreResearchers create a digital atlas for chronic lung disease.
Read MoreResearchers at Baylor College of Medicine developed novel software that can distinguish methylation patterns within bulk WGBS data.
Read MoreAn international team of researchers has identified a chain of events that matures the sperm and triggers their motility.
Read More